ELIECER
COTO GARCIA
Catedrático de Universidad
PABLO
AVANZAS FERNANDEZ
Profesor Asociado en CC. Salud
Publicaciones en las que colabora con PABLO AVANZAS FERNANDEZ (22)
2024
-
Survival analysis and gender differences in hypertrophic cardiomyopathy proband patients referred for genetic testing
International Journal of Cardiology, Vol. 408
2023
-
Chromosome Y Haplogroup R Was Associated with the Risk of Premature Myocardial Infarction with ST-Elevation: Data from the CholeSTEMI Registry
Journal of Clinical Medicine, Vol. 12, Núm. 14
-
Clinical Evaluation of Patients with Genetically Confirmed Familial Hypercholesterolemia
Journal of Clinical Medicine, Vol. 12, Núm. 3
-
Mitochondrial Heteroplasmy as a Marker for Premature Coronary Artery Disease: Analysis of the Poly-C Tract of the Control Region Sequence
Journal of Clinical Medicine, Vol. 12, Núm. 6
-
Opportunistic Genetic Screening for Familial Hypercholesterolemia in Heart Transplant Patients
Journal of Clinical Medicine, Vol. 12, Núm. 3
2022
2021
-
The APOB polymorphism rs1801701 A/G (p.R3638Q) is an independent risk factor for early-onset coronary artery disease: Data from a Spanish cohort
Nutrition, Metabolism and Cardiovascular Diseases, Vol. 31, Núm. 5, pp. 1564-1568
-
The renin–angiotensin–aldosterone system and coronavirus disease 2019
European Cardiology Review , Vol. 16
2020
-
Characterization of left ventricular non-compaction cardiomyopathy
Journal of Clinical Medicine, Vol. 9, Núm. 8, pp. 1-16
-
Clinical implications and gender differences of kcnq1 p.Gly168arg pathogenic variant in long qt syndrome
Journal of Clinical Medicine, Vol. 9, Núm. 12, pp. 1-12
-
Familial hypercholesterolemia in premature acute coronary syndrome. Insights from cholestemi registry
Journal of Clinical Medicine, Vol. 9, Núm. 11, pp. 1-12
-
IL17RA in early-onset coronary artery disease: Total leukocyte transcript analysis and promoter polymorphism (rs4819554) association
Cytokine, Vol. 136
2019
-
Gene variants in the NF-KB pathway (NFKB1, NFKBIA, NFKBIZ) and risk for early-onset coronary artery disease
Immunology Letters, Vol. 208, pp. 39-43
-
Spectral analysis of the QT interval increases the prediction accuracy of clinical variables in Brugada syndrome
Journal of Clinical Medicine, Vol. 8, Núm. 10
2018
-
Genetic variation at the long noncoding RNA H19 gene is associated with the risk of hypertrophic cardiomyopathy
Epigenomics, Vol. 10, Núm. 7, pp. 865-873
-
Role of syncope in predicting adverse outcomes in patients with suspected Brugada syndrome undergoing standardized flecainide testing
Europace, Vol. 20, Núm. FI1, pp. f64-f71
2017
-
Screening of the Filamin C Gene in a Large Cohort of Hypertrophic Cardiomyopathy Patients
Circulation: Cardiovascular Genetics, Vol. 10, Núm. 2
2016
-
Surveillance after cardiac arrest in patients with Brugada syndrome without an implantable defibrillator: An alarm effect of the previous syncope
International Journal of Cardiology, Vol. 218, pp. 69-74
2015
-
Time-dependent responses to provocative testing with flecainide in the diagnosis of Brugada syndrome
Heart Rhythm, Vol. 12, Núm. 2, pp. 350-357
2011
-
Mitochondrial DNA and TFAM gene variation in early-onset myocardial infarction: Evidence for an association to haplogroup H
Mitochondrion, Vol. 11, Núm. 1, pp. 176-181